Tocolytic drugs ineffective for premature birth after 30 weeks

FHS
March 4, 2025
3:12 am

The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health.

Adjuvant Immunotherapy in Early-Stage NSCLC

Adjuvant chemotherapy has been the standard of care for patients with resectable non-small cell lung cancer (NSCLC), but newer therapies are entering the mix as

June 30, 2023

ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan

A new investment firm affiliated with ARCH Venture Partners has raised $200 million for its first fund as it seeks to back scientific research out

December 2, 2023

Johns Hopkins, CareFirst, Techstars launch healthcare AI accelerator

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johns Hopkins University and insurer

August 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.